Friday, September 9

A Hybrid Event

Join us for the tenth anniversary of MedtechVision! Established in 2011, MedtechVision is an annual conference that brings together business leaders, inventors, investors, physicians and policymakers to discuss real-world solutions to the most challenging issues facing the Medtech industry today.

MedtechVision 2022


Hybrid Event
Expanding Horizons

More than ever, complex, connected and convergent technologies are pushing medtech into new areas beyond the boundaries of the traditional realm of healthcare. Therapeutics as software, devices or digital platforms are extending the care continuum of non-invasive patient care. We are accessing healthcare where we work, sleep or eat e.g. getting a rapid diagnostic test in our car at a drive-through clinic, using an AI-supported wearable to monitor diabetes or remotely participating in the clinical trial of a new therapeutic.

Adoption of new healthcare technology has historically been a hurdle to scaling novel digital solutions. COVID went a long way in pulling the bandaid off technology acceptance and presented us with an opportunity for a reset, a re-examination of existing models and a continued embrace of unparalleled innovation: expanding the future of accessible patient care.

Join us as we discuss how to maintain this momentum and fully realize the promise of new medical technologies that are expanding our horizons.

Date & Time

Friday, September 9, 2022
7:30am – 6pm PDT


$100 for the virtual meeting
$1,250 for In-Person



Register to attend Virtually



Share This


*This is a working agenda and subject to change.

7:30am - 8:30am

Registration & Breakfast

8:30am - 8:45am

Welcome from MedtechWomen & Stanford Biodesign

8:45am - 9:00am

A word from our Founders

9:00am - 9:45am

Patient Keynote

9:45am - 10:00am

Industry Landscape – Alira Health

10:00am - 10:15am


10:15am - 11:15am

Diagnostic Renaissance: Ramping Up Rapid Testing and Remote Patient Monitoring

Show More

Venture funding in global diagnostics startups increased >260% in 2021 vs. 2019 fueling a diagnostics renaissance (SV Bank Healthcare Report 2021). Point of care testing has been taken from the clinic and delivered directly to the patient’s door; digital technologies and wearables are enabling increased remote patient monitoring; and AI and machine learning are improving diagnostic solutions. These technologies can reduce resource pressures on hospitals and clinics as well as improve the speed and efficiency of the testing process and results. From COVID to cancer and from in-office to on-demand, this is a new industry and ours for the shaping.

11:15am - 12:30pm

Lunch & Networking

12:30pm - 12:45pm

Ferolyn Powell Award

12:45pm - 1:45pm

Remote Clinical Trials: Transitioning from the Traditional to the Modern

Show More

Remote clinical trials bypass the traditional limitations of site geography, improve participant diversity, and address the in-person staffing and data collection challenges that sharply limit the size of trials. They offer the rare value of reducing costs to sponsors while simultaneously improving the patient experience. The diagnostic renaissance and convergent technologies have continued to enable the expansion. However, regulatory guidance and industry standards are lagging. Clearing capturing the value of remote trials, while addressing their challenges will be key to moving remote trials from pandemic-era stop-gap to a new standard for medical device evaluation.

1:45pm - 2:15pm

Executive Interview – Lisa Earnhardt, Abbott

2:15pm - 2:30pm


2:30am - 3:30pm

The Promise of Convergent Technologies

Show More

The convergence of complex technology advancements in sensored wearables, miniaturization, telecommunications, software and new delivery models is creating a new horizon for disruptive, cost-efficient, healthcare solutions.

Paradigm shifts in medtech are transforming patient care from invasive to non-invasive, intervention to prevention, and hospitals to the home. We see technologies that can expand patient access via telehealth or wearables to more effectively manage chronic disease wherever the patient is located. Further, these novel convergent technologies are creating new definitions of therapeutics eg. bioelectronic medicine or digital platforms to better engage, educate and treat patients.

3:30pm - 3:45pm

Closing Remarks

3:45pm - 6:00pm

Networking Reception

Speakers will be added as bios become available.

Moderators will be added as bios become available.